FAM
FULC icon

Fred Alger Management’s Fulcrum Therapeutics FULC Stock Holding History

Fred Alger Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,921
Closed -$1.16M – 521
2022
Q1 		$1.16M Buy
+48,921
New +$692K ﹤0.01% 379
2020
Q2 		– Sell
-16,281
Closed -$194K – 532
2020
Q1 		$194K Sell
16,281
-31,500
-66% -$504K ﹤0.01% 396
2019
Q4 		$795K Sell
47,781
-59,357
-55% -$567K ﹤0.01% 359
2019
Q3 		$711K Buy
+107,138
New +$1.19M ﹤0.01% 356

Other funds holding FULC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fred Alger Management's FULC Position: Q2 2022 in Review

Fred Alger Management sold out of Fulcrum Therapeutics (FULC) in Q2 2022, closing a stake of 48,921 shares — an estimated $1.16M sold.

Fred Alger Management first reported a position in FULC in Q3 2019 and held it in 4 quarters. The position peaked at $1.16M in Q1 2022. 101 funds tracked by Wall St. Rank hold FULC as of Q2 2022.

  • Fred Alger Management reported no remaining Fulcrum Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Fred Alger Management sold 48,921 Fulcrum Therapeutics shares in Q2 2022, an estimated $1.16M.
  • Fred Alger Management first reported a position in Fulcrum Therapeutics in Q3 2019 and held it in 4 quarters.
  • Fred Alger Management's Fulcrum Therapeutics position peaked at $1.16M in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.